Physician

Alexandra Bourgeois

According to 2025 Medicare claims, Alexandra Bourgeois (NPI: 1750813283) practices dermatology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ADVANCED DERMATOLOGY AND SKIN SURGERY, PA (NPI: 1215990700; TIN: 550801575) and primary practice location at 28803-2493. Bourgeois is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Bourgeois' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 4,167 HCPCS/CPT codes, and received $205,431 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 919 prescription claims across 462 beneficiaries totaling $330,117 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 35 records totaling $729. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $18,455 to $330,117. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$106K$212K2021 Medicare payment: $61,631 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $196,249 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $211,893 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $205,431 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20212811,112$61,631
20228163,993$196,249
20239904,429$211,893
20241,0544,167$205,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$165K$330K2019 Drug cost: $18,455 (USD; Tot_Drug_Cst)2020 Drug cost: $58,824 (USD; Tot_Drug_Cst)2021 Drug cost: $116,661 (USD; Tot_Drug_Cst)2022 Drug cost: $241,114 (USD; Tot_Drug_Cst)2023 Drug cost: $211,046 (USD; Tot_Drug_Cst)2024 Drug cost: $330,117 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191948$18,455
20202548$58,824
2021100184$116,661
2022368761$241,114
2023386744$211,046
2024462919$330,117

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths265294$75
11102Biopsy of related skin growth, first growth350409$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more712905$59
17000Destruction of precancer skin growth, 1 growth389471$35
17003Destruction of precancer skin growth, 2-14 growths2561,048$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab25784$109,642
Taltz AutoinjectorIxekizumab16448$108,281
FluorouracilFluorouracil681,962$4,775
Clobetasol PropionateClobetasol Propionate1082,964$4,414
KetoconazoleKetoconazole1424,191$1,886

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$729Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandra Bourgeois?

Tedicare shows public-source Medicare data for Alexandra Bourgeois (NPI 1750813283), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Bourgeois have ACO affiliation data?

Alexandra Bourgeois is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Alexandra Bourgeois?

Alexandra Bourgeois is linked to ADVANCED DERMATOLOGY AND SKIN SURGERY, PA (billing NPI 1215990700) in the available physician profile data.

Does Alexandra Bourgeois have Open Payments data?

Alexandra Bourgeois has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.